Teva Gets Bayer's Cancer Drug Patent Invalidated In UK
A London judge on Friday invalidated a Bayer patent for a liver and kidney cancer drug, clearing the way for generic-drug maker Teva to release its own version of the product....To view the full article, register now.
Already a subscriber? Click here to view full article